MedTrace Logo

Best Therapy for Patients With Neuroendocrine Tumors

NCT00815620 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2017-03-21

No results posted yet for this study

Summary

A prospective observational study containing three arms comprising different therapeutic measures to treat patients with neuroendocrine tumors in advanced stages. The therapy arms include local ablative therapy such as TACE or SIRT, surgery and RFA with peptide receptor radiotherapy.

Conditions

Sponsors & Collaborators

  • Zentralklinik Bad Berka

    lead OTHER

Principal Investigators

  • Dieter Hörsch, MD · Zentralklinik Bad Berka GmbH

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-11-30
Primary Completion
2016-08-31
Completion
2017-03-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00815620 on ClinicalTrials.gov